Jump Financial, LLC Jounce Therapeutics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$2.8 - $7.67 $102,200 - $279,955	36,500 New	36,500 $111,000
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $307,147 - $532,023	-60,942 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.58 - $10.66 $400,998 - $649,641	60,942 New	60,942 $414,000
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $69,319 - $142,861	-10,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.37 - $10.33 $65,611 - $106,399	10,300 New	10,300 $72,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.